• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

82.06 -8.62 (-9.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 876,184
Open 89.22
Bid (Size) 81.50 (100)
Ask (Size) 89.96 (100)
Prev. Close 90.68
Today's Range 81.60 - 90.88
52wk Range 55.17 - 170.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Power Solutions Stock Up 140% as $6.36 Million Exit Follows 62% Sales Surge ↗
February 16, 2026
Power Solutions International designs and manufactures advanced engines and power systems for industrial and transportation markets. 
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
Freshworks Falls 60% in a Year as $7.5 Million Sale Shrinks Stake to 3.1% of This Portfolio's Assets ↗
February 16, 2026
This SaaS firm delivers cloud-based business software worldwide, focusing on subscription-driven customer and IT service solutions. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
-38.0%
-38.0%
1 Month
-19.5%
-19.5%
3 Month
-49.1%
-49.1%
6 Month
-32.7%
-32.7%
1 Year
-14.4%
-14.4%

More News

Read More
News headline image
Air Lease Stock Up 43% as Investor Trims $6.9 Million Stake Despite $1 Billion Profit Year ↗
February 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Five9 Stock Down 60% This Past Year, but One Investor Just Lifted Stake With $3.5 Million Buy ↗
February 16, 2026
Via The Motley Fool
News headline image
Freshworks Stock Down 60% in One Year as Revenue Jumps 16% and One Investor Sells $7 Million in Shares ↗
February 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health
February 11, 2026
From GeneDx
Via Business Wire
News headline image
GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
February 03, 2026
From GeneDx
Via Business Wire
News headline image
The Great Rotation: Small-Caps Stand Tall as AI Exhaustion Triggers Tech Rout
January 29, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The Great Rotation of 2026: Why Wall Street is Abandoning Big Tech for Main Street Small Caps
January 28, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Great AI Pivot: From Massive Build-Out to the Era of Operational ROI
January 27, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Workforce
News headline image
The Great Rotation: Wall Street’s ‘Earnings Handoff’ Moves from Silicon Valley to Main Street
January 26, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Earnings
News headline image
The Great Rotation: Small-Caps Set to Outpace ‘Magnificent 7’ in Historic Earnings Handoff
January 26, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
January 25, 2026
Via The Motley Fool
News headline image
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
January 24, 2026
Via The Motley Fool
News headline image
The Great Rotation of 2026: Why Wall Street is Betting Big on the Russell 2000
January 22, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
January 15, 2026
From Halper Sadeh LLC
Via Business Wire
News headline image
The Great Rotation: Small-Cap Stocks Surge in Early 2026 as Market Leadership Broadens
January 13, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Great Rotation: Small-Caps Log Longest Winning Streak Against S&P 500 Since 2019
January 12, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
January 12, 2026
From GeneDx
Via Business Wire
News headline image
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
January 08, 2026
From GeneDx
Via Business Wire
News headline image
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
January 07, 2026
From GeneDx
Via Business Wire
News headline image
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
January 06, 2026
From GeneDx
Via Business Wire
News headline image
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
January 05, 2026
From GeneDx
Via Business Wire
News headline image
BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era
January 02, 2026
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
December 30, 2025
From GeneDx
Via Business Wire

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 82.06
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 02/20/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap